Compile Data Set for Download or QSAR
Report error Found 271 Enz. Inhib. hit(s) with all data for entry = 3012
TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388385BDBM388385(US10294246, Compound No. 82)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388386BDBM388386(US10294246, Compound No. 83)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388381BDBM388381(US10294246, Compound No. 78)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388380BDBM388380(US10294246, Compound No. 77)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388382BDBM388382(US10294246, Compound No. 79)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388393BDBM388393(US10294246, Compound No. 90)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388392BDBM388392(US10294246, Compound No. 89)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388395BDBM388395(US10294246, Compound No. 92)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388394BDBM388394(US10294246, Compound No. 91)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388389BDBM388389(US10294246, Compound No. 86)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388388BDBM388388(US10294246, Compound No. 85)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388401BDBM388401(US10294246, Compound No. 98)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388397BDBM388397(US10294246, Compound No. 94)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388396BDBM388396(US10294246, Compound No. 93)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388398BDBM388398(US10294246, Compound No. 95)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388409BDBM388409(US10294246, Compound No. 106)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388408BDBM388408(US10294246, Compound No. 105)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388411BDBM388411(US10294246, Compound No. 108)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388404BDBM388404(US10294246, Compound No. 101)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388407BDBM388407(US10294246, Compound No. 104)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388417BDBM388417(US10294246, Compound No. 114)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388416BDBM388416(US10294246, Compound No. 113)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388419BDBM388419(US10294246, Compound No. 116)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388418BDBM388418(US10294246, Compound No. 122 | US10294246, Compoun...)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388412BDBM388412(US10294246, Compound No. 109)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388415BDBM388415(US10294246, Compound No. 112 | [2-(benzofuran-3-yl...)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388414BDBM388414(US10294246, Compound No. 111)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388424BDBM388424(US10294246, Compound No. 121)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388427BDBM388427(US10294246, Compound No. 124)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388426BDBM388426(US10294246, Compound No. 123)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388423BDBM388423(US10294246, Compound No. 120)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388422BDBM388422(US10294246, Compound No. 119)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388433BDBM388433(US10294246, Compound No. 130)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388304BDBM388304(US10294246, Compound No. 1)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388432BDBM388432(US10294246, Compound No. 129)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388307BDBM388307(US10294246, Compound No. 4)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388435BDBM388435(US10294246, Compound No. 132)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388306BDBM388306(US10294246, Compound No. 3)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388434BDBM388434(US10294246, Compound No. 131)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388429BDBM388429(US10294246, Compound No. 126)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388428BDBM388428(US10294246, Compound No. 125)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388431BDBM388431(US10294246, Compound No. 128)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388313BDBM388313(US10294246, Compound No. 10)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388312BDBM388312(US10294246, Compound No. 9)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388315BDBM388315(US10294246, Compound No. 12)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388314BDBM388314(US10294246, Compound No. 11)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388309BDBM388309(US10294246, Compound No. 6)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388437BDBM388437(US10294246, Compound No. 134)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388308BDBM388308(US10294246, Compound No. 5)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 388311BDBM388311(US10294246, Compound No. 8)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immunoproteasome (0.25 nM) and se...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
US Patent

Displayed 1 to 50 (of 271 total ) | Next | Last >>
Jump to: